Aurora Cannabis Inc. (NYSE:ACB) was the recipient of a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 26,690,000 shares, a growth of 31.9% from the February 28th total of 20,230,000 shares. Approximately 13.6% of the company’s shares are short sold. Based on an average trading volume of 23,200,000 shares, the short-interest ratio is currently 1.2 days.
A number of institutional investors have recently bought and sold shares of ACB. Advisory Services Network LLC lifted its stake in shares of Aurora Cannabis by 87.6% in the 4th quarter. Advisory Services Network LLC now owns 3,005 shares of the company’s stock worth $25,000 after acquiring an additional 1,403 shares during the period. International Assets Investment Management LLC acquired a new stake in shares of Aurora Cannabis in the 4th quarter worth approximately $31,000. Tradewinds Capital Management LLC lifted its stake in shares of Aurora Cannabis by 38.8% in the 4th quarter. Tradewinds Capital Management LLC now owns 5,045 shares of the company’s stock worth $42,000 after acquiring an additional 1,409 shares during the period. Banque Cantonale Vaudoise lifted its stake in shares of Aurora Cannabis by 111.1% in the 4th quarter. Banque Cantonale Vaudoise now owns 5,500 shares of the company’s stock worth $46,000 after acquiring an additional 2,895 shares during the period. Finally, Wells Fargo & Company MN lifted its stake in shares of Aurora Cannabis by 32.5% in the 4th quarter. Wells Fargo & Company MN now owns 5,917 shares of the company’s stock worth $49,000 after acquiring an additional 1,453 shares during the period. 11.86% of the stock is owned by hedge funds and other institutional investors.
ACB has been the subject of several recent analyst reports. MKM Partners cut shares of Aurora Cannabis from a “neutral” rating to a “sell” rating in a research note on Friday, February 12th. Jefferies Financial Group reiterated an “underperform” rating and issued a $4.59 price target on shares of Aurora Cannabis in a report on Monday, January 4th. BMO Capital Markets lowered shares of Aurora Cannabis from a “market perform” rating to an “underperform” rating and set a $9.00 price target on the stock. in a report on Thursday, December 17th. Desjardins lowered shares of Aurora Cannabis from a “hold” rating to a “sell” rating in a report on Friday, February 12th. Finally, CIBC lifted their price target on shares of Aurora Cannabis from $17.00 to $18.50 and gave the company a “neutral” rating in a report on Tuesday, February 16th. Seven equities research analysts have rated the stock with a sell rating and nine have issued a hold rating to the company. The company has a consensus rating of “Hold” and an average target price of $11.47.
Aurora Cannabis stock opened at $9.14 on Friday. The company has a quick ratio of 1.07, a current ratio of 1.88 and a debt-to-equity ratio of 0.17. The firm has a 50-day moving average price of $10.88 and a two-hundred day moving average price of $8.91. The firm has a market capitalization of $1.81 billion, a price-to-earnings ratio of -0.37 and a beta of 3.44. Aurora Cannabis has a 52-week low of $3.71 and a 52-week high of $19.68.
Aurora Cannabis (NYSE:ACB) last posted its earnings results on Thursday, February 11th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.09). The firm had revenue of $51.93 million for the quarter, compared to analyst estimates of $54.66 million. Aurora Cannabis had a negative net margin of 1,238.94% and a negative return on equity of 16.32%. Research analysts expect that Aurora Cannabis will post -1.17 earnings per share for the current year.
Aurora Cannabis Company Profile
Aurora Cannabis Inc produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.
Featured Story: Net Margin – Understanding the Different Kinds of Profit
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]